James R. Gruber - Apr 11, 2022 Form 3 Insider Report for Eton Pharmaceuticals, Inc. (ETON)

Role
Chief Financial Officer
Signature
/s/ James Gruber
Stock symbol
ETON
Transactions as of
Apr 11, 2022
Transactions value $
$0
Form type
3
Date filed
4/14/2022, 04:05 PM
Next filing
Jul 18, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ETON Employee Stock Options Apr 11, 2022 Common Stock 100K $3.81 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Stock options awarded on April 11, 2022 to Reporting Person pursuant to the Company's 2018 Equity Incentive Plan (the "Plan"). The stock options vest contingent upon continued employment as follows: 25, 000 on April 11, 2023, 25,000 on April 11, 2024, 25,000 on April 11, 2025 and 25,000 on April 11, 2026.